Impact of pretreatment body mass index on the survival of head and neck cancer patients

Zheng Yang(Beijing Tongren Hospital), Neil D. Gross(The University of Texas MD Anderson Cancer Center), Peng Sun(Biogen (United States)), Guojun Li(Ministry of Education of the People's Republic of China), Kristina R. Dahlstrom(Baylor College of Medicine), Peng Wei(Creighton University), Jobran Mansour(Sheba Medical Center), Mark Zafereo(The University of Texas MD Anderson Cancer Center)
Head & Neck
January 25, 2024
10.1002/hed.27659
Cited by 10

Related Papers

Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies
|Human Molecular Genetics|2014|1.2k
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia—TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trial
|The Lancet|2015|518
Gut commensal <i>Parabacteroides distasonis</i> alleviates inflammatory arthritis
|Gut|2023|237
Complete Surgical Resection Following Neoadjuvant Dabrafenib Plus Trametinib in <i> BRAF <sup>V600E</sup> </i> -Mutated Anaplastic Thyroid Carcinoma
|Thyroid|2019|229
Diagnosis and Management of Squamous Cell Carcinoma of Unknown Primary in the Head and Neck: ASCO Guideline
|Journal of Clinical Oncology|2020|229